Profound Medical Congratulates Texas Prostate on Achieving 100th TULSA Procedure™ Milestone

Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ...

Francis Medical Announces First Commercial Vanquish® Procedure on the East Coast for Prostate Tissue Ablation

Francis Medical, Inc., a privately held medical device company, announced today the successful completion of the first commercial (non-clinical study) procedure on the East Coast using the Vanquish® ...
Morningstar

Francis Medical Announces First Commercial Vanquish® Procedures in Arizona for Prostate Tissue Ablation

The procedures were performed on patients diagnosed with localized prostate cancer by Dr. Rahul Mehan with East Valley Urology Center of Arizona, at the Verve Surgery Center in Mesa, Ariz. These ...
Morningstar

Francis Medical Announces First Commercial Procedure with the Vanquish® Water Vapor System for Prostate Tissue Ablation

MINNEAPOLIS, Feb. 3, 2026 /PRNewswire/ -- Francis Medical, Inc., a privately-held medical device company, announced the first commercial procedure using the Vanquish Water Vapor Ablation System at ...

Francis Medical Announces First Commercial Vanquish(R) Procedure on the East Coast for Prostate Tissue Ablation

Francis Medical, Inc., a privately held medical device company, announced today the successful completion of the first commercial (non-clinical study) procedure on the East Coast using the Vanquish(R) ...